Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ferriprotoporphyrin IX (FP-IX), or hematin, is a toxic byproduct produced during the digestion of host hemoglobin by the malaria parasite Plasmodium falciparum (Sullivan, 2002). This process occurs within the parasite's acidic food vacuole, where hemoglobin is broken down to provide amino acids for growth. Because free hematin can generate reactive oxygen species and damage parasite membranes, the parasite detoxifies it by sequestering it into an insoluble crystalline form known as hemozoin or malaria pigment (Hempelmann, 2007). This detoxification pathway is a critical therapeutic target; quinoline-based antimalarials like chloroquine and quinine work by binding to hematin and preventing its crystallization (Egan, 2008). The resulting accumulation of free, toxic hematin leads to the lysis of the parasite's digestive vacuole and subsequent cell death. Despite its historical success as a target, mutations in parasite transporters such as PfCRT have led to widespread resistance by reducing drug concentration at the site of hematin interaction.
Inhibition of hemozoin formation (biocrystallization) by binding to ferriprotoporphyrin IX (hematin), which prevents its detoxification and leads to the accumulation of toxic free heme that causes oxidative damage and parasite death (Egan, 2008; Hempelmann, 2007).
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ferriprotoporphyrin IX (Hematin) (FP-IX).